thiazolidines has been researched along with Corneal Injuries in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, X; Duan, T; Koprivica, V; Lee, S; Levin, MH; Pasricha, ND; Schallhorn, JM; Verkman, AS; Zhang, T | 1 |
| Ichikawa, K; Iwanishi, H; Miyajima, M; Okada, Y; Reinach, PS; Saika, S; Sumioka, T; Yasuda, S | 1 |
2 other study(ies) available for thiazolidines and Corneal Injuries
| Article | Year |
|---|---|
Nanomolar Potency Aminophenyltriazine CFTR Activator Reverses Corneal Epithelial Injury in a Mouse Model of Dry Eye.
Topics: Administration, Topical; Animals; Benzoates; Cautery; Chloride Channels; Corneal Injuries; Cystic Fibrosis Transmembrane Conductance Regulator; Disease Models, Animal; Dry Eye Syndromes; Female; Lacrimal Apparatus; Lissamine Green Dyes; Mice; Mice, Inbred BALB C; Nanotechnology; Tears; Thiazolidines; Treatment Outcome; Triazines | 2020 |
Loss of sphingosine 1-phosphate receptor 3 gene function impairs injury-induced stromal angiogenesis in mouse cornea.
Topics: Animals; Cells, Cultured; Cornea; Corneal Injuries; Human Umbilical Vein Endothelial Cells; Humans; Mice; Mice, Knockout; Neovascularization, Physiologic; Signal Transduction; Sphingosine-1-Phosphate Receptors; Thiazolidines | 2021 |